| Period of 12 | Period of 12 | Period of 12 | Period of 12 | ||||
| months ended | months ended | months ended | months ended | ||||
| Note | 31-12-2024 | 31-12-2023 | Note | 31-12-2024 | 31-12-2023 | ||
| Continued operations | Other comprehensive income – item that may | ||||||
Revenue | 9 | be reclassified to profit or loss | |||||
Other operating income | Exchange differences from the translation of | ( | |||||
Depreciation and amortisation | 10 | foreign operations, net of tax | |||||
Raw materials and consumables | Share of other comprehensive income/(loss) of | ( | |||||
External services | 11 | Associates, accounted for using the equity method | |||||
Taxes and charges | Other comprehensive income, net of tax | ||||||
| Total comprehensive income attributable | |||||||
Payroll | 12 | to the owners of the parent 2 | |||||
Social security and other benefits | 12 | Net profit (loss) attributable to owners of the parent company: | |||||
Other expenses | 13 | From continued operations: | |||||
Cost of goods and materials sold | From discontinued operations: | ||||||
Other operating expenses | Total comprehensive income attributable to owners | ||||||
Impairment (gain)/loss on trade and other receivables | 25 | of the parent company: | |||||
Total operating expenses | From continued operations | ||||||
Operating profit | From discontinued operations | ||||||
Finance income | 14 | Basic earnings per share (in PLN) | 16 | ||||
Finance costs | 14 | Basic earnings per share (in PLN) – continuing operations | 16 | ||||
| Share of results from associates, accounted for using | 19 | ( | Basic earnings per share (in PLN) – discontinued operations | 16 | |||
| the equity method | Diluted earnings per share (in PLN) | 16 | |||||
| Gain on revaluation of previously owned shares | 18.2 | ||||||
| in acquired entities | Diluted earnings per share (in PLN) – continuing operations | 16 | |||||
Profit before tax | Diluted earnings per share (in PLN) – discontinued operations | 16 | |||||
Income tax expense | 15 | ||||||
Profit from continuing operations | |||||||
Profit (loss) from discontinued operations 1 | |||||||
Net profit |
| Balance as at | Balance as at | Balance as at | Balance as at | |||||
ASSETS | Note | 31-12-2024 | 31-12-2023 | EQUITY AND LIABILITIES | Note | 31-12-2024 | 31-12-2023 | |
Goodwill | 18 | Share capital | 36 | |||||
Intangible assets | 21 | Share premium | ||||||
Property, plant, and equipment | 22 | Retained earnings/(accumulated losses) | ||||||
| Investments in associates, accounted for | 19 | Reserves | ( | ( | ||||
| using the equity method | Total equity (attributable to owners) | |||||||
Other receivables | Loans and borrowings | 27 | ||||||
Other financial assets | 33.2 | Employee benefits and other provisions | 29 | |||||
Deferred tax assets | 15.3 | Government grants | ||||||
Other assets | 24 | Deferred tax liability | 15.3 | |||||
Non-current assets | Other financial liabilities | 23.2 | ||||||
Inventory | Total non-current liabilities | |||||||
Other financial assets | 20 | Trade payables and other payables | 32 | |||||
Trade and other receivables | 25 | Loans and borrowings | 27 | |||||
Income tax asset | Current tax liabilities | |||||||
Other assets | 24 | Employee benefits and other provisions | 29 | |||||
Cash and cash equivalents | 26 | Other financial liabilities | 23.2 | |||||
Current assets | Other liabilities | 31 | ||||||
TOTAL ASSETS | ||||||||
Total current liabilities | ||||||||
TOTAL EQUITY AND LIABILITIES | ||||||||
| The above consolidated financial statements should be read in conjunction with the accompanying notes. |
| InPost Group | |||||||
| Integrated Annual Report 2024 | |||||||
| CONSOLIDATED FINANCIAL STATEMENTS OF INPOST GROUP FOR THE PERIOD OF 12 MONTHS ENDED ON 31 DECEMBER, 2024 (IN MILLIONS PLN) / | |||||||
| CONSOLIDATED STATEMENT OF CASH FLOWS | |||||||
| Consolidated statement | |||||||
| of cash flows | Period of 12 months | Period of 12 months | Period of 12 months | Period of 12 months | |||
| Note | ended 31-12-2024 | ended 31-12-2023 | ended 31-12-2024 | ended 31-12-2023 | |||
| Cash flows from operating activities | Cash flows from investing activities | ||||||
Net profit | Purchase of property, plant, and equipment | ( | ( | ||||
Adjustments: | Purchase of intangible assets | ( | ( | ||||
Income tax expense | 15 | Acquisition of shares in associated company | 19 | ( | |||
Financial cost/(income) | 35 | Proceeds from financial instruments | |||||
(Gain)/loss on sale of property, plant, and equipment | Acquisition of a subsidiary, net of cash acquired | 18.2 | ( | ||||
Depreciation and amortisation | 10 | Loans granted | 20 | ( | |||
Impairment losses | Net cash from investing activities | ( | ( | ||||
Share-based payments | 30 | Cash flows from financing activities | |||||
| Gain on revaluation of previously owned shares | ( | Proceeds from loans and borrowings | 28 | ||||
| in acquired entities | Repayment of the principal portion of loans | 28 | ( | ( | |||
Share of results of associates | 19 | ( | and borrowings | ||||
Changes in working capital: | ( | ( | Payment of principal portion of the lease liability | 28 | ( | ( | |
Trade and other receivables | 35 | ( | ( | Acquisition of treasury shares | ( | ||
Inventories | Net cash from financing activities | ( | ( | ||||
Other assets | 35 | ( | ( | Net increase/(decrease) in cash and cash equivalents | |||
Trade payables and other payables | 35 | Cash and cash equivalents as at 1 January | |||||
Employee benefits, provisions, and contract liabilities | 35 | Effect of movements in exchange rates on cash held | |||||
Other liabilities | 35 | Cash and cash equivalents as at 31 December | |||||
Cash generated from operating activities | |||||||
Interest and commissions paid | ( | ( | |||||
Income tax paid | ( | ( | |||||
Net cash from operating activities |
| Reserves | ||||||||
Share capital | Share premium | Translation reserve 3 | Treasury shares | Reserve capital | Other reserves 5 | Retained earnings/ | Total equity | |
(reorganisation) 4 | (accumulated losses) | (attributable to owners) | ||||||
Balance as at 01-01-2023 | ( | ( | ( | |||||
Net profit | ||||||||
| Other comprehensive income – exchange | ||||||||
| differences from translation of subsidiaries | ||||||||
| Share in other comprehensive income/(loss) | ( | ( | ||||||
| of associates | ||||||||
Total comprehensive income for the period | ||||||||
Share-based payment (equity-settled) | ||||||||
Acquisition of treasury shares | ||||||||
Treasury shares delivered | ( | |||||||
Balance as at 31-12-2023 | ( | ( | ||||||
Net profit | ||||||||
| Other comprehensive income – exchange | ( | ( | ||||||
| differences from translation of subsidiaries | ||||||||
| Share in other comprehensive income/(loss) | ||||||||
| of associates | ||||||||
Total comprehensive income for the period | ||||||||
Share-based payment (equity-settled) | ||||||||
Acquisition of treasury shares | ( | ( | ||||||
Treasury shares delivered | ( | |||||||
Balance as at 31-12-2024 | ( | ( |